Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism

Journal of Human Hypertension

Volumn 18, Issue 1, 2004, Pages 47-51

  Fallo, Francesco ^a   Pilon, C ^a   Williams, T A ^b   Sonino, N ^a   Morra Di Cella, S ^b   Veglio, F ^b   De Iasio, R ^c   Montanari, P ^d   Mulatero, P ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d City Hospital of Montecchio Emilia   (Italy)

Author keywords

Genotype; Glucocorticoid remediable aldosteronism; Phenotype

Indexed keywords

18 HYDROXYHYDROCORTISONE; 18 OXOHYDROCORTISONE; ALDOSTERONE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTERONE; CORTICOTROPIN; CYTOCHROME P450 1B1; CYTOCHROME P450 2B; DEOXYCORTICOSTERONE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; NIFEDIPINE; POTASSIUM; SPIRONOLACTONE; TETRACOSACTIDE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CHIMERA; CLINICAL FEATURE; ENZYME ACTIVITY; EXON; FAMILY; FATHER; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; INTRON; MALE; PHENOTYPE; PLASMA RENIN ACTIVITY; POLYMERASE CHAIN REACTION; POTASSIUM BLOOD LEVEL; SEQUENCE ANALYSIS; SIBLING; SOUTHERN BLOTTING;

ADULT; AGED; ALDOSTERONE; ALDOSTERONE SYNTHASE; CORTODOXONE; DEXAMETHASONE; FEMALE; GENOTYPE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; RENIN; STEROID 11-BETA-HYDROXYLASE;

EID: 0842308015     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001636     Document Type: Article

References (22)

1. Sutherland DJA, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 1966; 95: 1109-1119.
2. Dluhy RG, Lifton RF. Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1999; 84: 4341-4344.
3. Stowasser M, Gordon RD. Primary aldosteronism: Learning from the study of familial varieties. J Hypertens 2000; 18: 1165-1176.
4. Lifton RB et al. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid remediable aldosteronism and human hypertension. Nature 1992; 35: 262-265.
5. Mulatero P et al. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: Aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab 1998; 83: 2573-2575.
6. Pascoe L, Curnow KM, New MI, Corvol P. The relationship between phenotype and genotype on glucocorticoid-suppressible hyperaldosteronism (GSH). In: New MI (ed). Where Phenotype Does Not Match Genotype, Ares-Serono Symposia Series - Frontiers in Endocrinology, Vol. 16. Ares-Serono: Rome, 1996, pp 69-79.
7. Dluhy RG, Lifton RP. Phenotypic variation in glucocorticoid-remediable aldosteronism (GRA). In: New MI (ed). Where Phenotype Does Not Match Genotype, Ares-Serono Symposia Series - Frontiers in Endocrinology, Vol. 16. Ares-Serono: Rome, 1996, pp 81-90.
8. Fallo F et al. A new family with dexamethasone-suppressible hyperaldosteronism: Aldosterone unresponsiveness to angiotensin II. Clin Endocrinol (Oxf) 1985; 22: 777-785.
9. Rich GM et al. Glucocorticoid-remediable aldosteronism in a large kindred: Clinical spectrum and diagnosis using a characteristics biochemical phenotype. Ann Intern Med 1992; 116: 813-820.
10. Gates LJ et al. Variation of phenotype in patients with glucocorticoid remediable aldosteronism. J Med Genet 1996; 33: 25-28.
11. Mulatero P et al. Glucocorticoid remediable aldosteronism: Low morbidity and mortality in a four-generation italian pedigree. J Clin Endocrinol Metab 2002; 87: 3187-3191.
12. Boschi S et al. Measurement of steroid hormones in plasma by isocratic high performance liquid chromatography coupled by radioimmunoassay. Clin Chim Acta 1994; 231: 107-113.
13. Gomez-Sanchez CE, Leon LM, Gomez-Sanchez EP. Biotin-hydrazide derivatives for the development of steroid enzyme-linked immunoassay. J Steroid Biochem Mol Biol 1992; 43: 523-527.
14. Yamakita N et al. Simultaneous measurement of plasma 18-oxocortisol and 18-hydroxycortisol levels in normal man. Eur J Endocrinol 1994; 131: 74-79.
15. Mulatero P et al. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 1998; 83: 3996-4001.
16. 2 receptor and α-adducin gene polymorphisms. J Clin Endocrinol Metab 2002; 87: 3337-3343.
17. Ganguly A, Weinberger MH, Guthrie GP, Fineberg NS. Adrenal steroid response to ACTH in glucocorticoid-suppressible aldosteronism. Hypertension 1984; 6: 563-567.
18. Jamieson A et al. Altered 11β-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism. J Clin Endocrinol Metab 1996; 81: 2298-2302.
19. Fallo F, Kuhnle U, Boscaro Ma, Sonino N. Abnormality of aldosterone and cortisol late pathways in glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1994; 79: 772-774.
20. Curnow KM et al. The amino acid substitutions Ser288Gly and Val320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme. Nat Struct Biol 1997; 1: 32-35.
21. Pascoe L et al. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyl oxidase II deficiency. Proc Natl Acad Sci 1992; 89: 4996-5000.
22. WAsniewska M et al. Aldosterone synthase deficiency type 1 with no documented mutations in the CYP11B2 gene. Eur J Endocrinol 2001; 144: 59-62.